{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:50:15Z","timestamp":1792515015445,"version":"4.5.0"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T00:00:00Z","timestamp":1634342400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.intimp.2021.108272","type":"journal-article","created":{"date-parts":[[2021,10,29]],"date-time":"2021-10-29T05:54:44Z","timestamp":1635486884000},"page":"108272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"special_numbering":"PB","title":["Auranofin: Past to Present, and repurposing"],"prefix":"10.1016","volume":"101","author":[{"given":"Masamichi","family":"Yamashita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.intimp.2021.108272_b0005","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/ard.35.3.251","article-title":"Auranofin. New oral gold compound for treatment of rheumatoid arthritis","volume":"35","author":"Finkelstein","year":"1976","journal-title":"Ann. Rheum Dis."},{"issue":"3 Pt 1","key":"10.1016\/j.intimp.2021.108272_b0010","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/0091-6749(84)90261-6","article-title":"Auranofin, an oral chrysotherapeutic agent, inhibits histamine release from human basophils","volume":"74","author":"Takaishi","year":"1984","journal-title":"J. Allergy Clin. Immunol."},{"issue":"9","key":"10.1016\/j.intimp.2021.108272_b0015","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/0006-2952(87)90113-4","article-title":"Differential inhibitory effects of auranofin on leukotriene B4 and leukotriene C4 formation by human polymorphonuclear leukocytes","volume":"36","author":"Honda","year":"1987","journal-title":"Biochem Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2021.108272_b0020","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0091-6749(88)90213-8","article-title":"An open study of auranofin in the treatment of steroid-dependent asthma","volume":"81","author":"Bernstein","year":"1988","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2021.108272_b0025","first-page":"288","article-title":"Oral gold therapy in steroid-dependent asthma, nasal polyposis, and aspirin hypersensitivity","volume":"65","author":"McNeil","year":"1990","journal-title":"Ann Allergy."},{"key":"10.1016\/j.intimp.2021.108272_b0030","series-title":"Clinical Aspects of Immunology. The first","first-page":"317","article-title":"Classification of allergic reactions underlying disease","author":"Coombs","year":"1963"},{"issue":"9","key":"10.1016\/j.intimp.2021.108272_b0035","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.intimp.2021.108272_b0040","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1002\/art.27580","article-title":"The 2010 American College of Rheumatology\/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report","volume":"62","author":"Neogi","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2021.108272_b0045","first-page":"1","article-title":"Use of NSAIDs in treating patients with arthritis","author":"Crofford","year":"201315","journal-title":"Arthritis Research & Therapy."},{"issue":"3","key":"10.1016\/j.intimp.2021.108272_b0050","doi-asserted-by":"crossref","first-page":"216","DOI":"10.2174\/1568010033484142","article-title":"Effects of chrisotherapeutic gold compounds on prostaglandin E2 production","volume":"2","author":"Yamashita","year":"2003","journal-title":"Curr. Drug Targets-Inflammation Allergy."},{"issue":"3","key":"10.1016\/j.intimp.2021.108272_b0055","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1248\/yakushi1947.120.3_265","article-title":"Analysis of the mechanism for the anti-inflammatory effect of the anti- rheumatic drug auranofin","volume":"120","author":"Yamashita","year":"2000","journal-title":"Yakugaku Zasshi"},{"issue":"16","key":"10.1016\/j.intimp.2021.108272_b0060","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.2174\/1389450117666161005152327","article-title":"Aspirin Intolerance: Experimental Models for Bed-to-Bench","volume":"17","author":"Yamashita","year":"2016","journal-title":"Curr. Drug Targets"},{"issue":"2\u20133","key":"10.1016\/j.intimp.2021.108272_b0065","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0014-2999(97)00118-0","article-title":"Dual effects of auranofin on prostaglandin E2 production by rat peritoneal macrophages","volume":"325","author":"Yamashita","year":"1997","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2021.108272_b0070","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0022-3565(24)36685-6","article-title":"Prostaglandin E2 production dependent upon cyclooxygenase-1 and cyclooxygenase-2 and its contradictory modulation by auranofin in rat peritoneal macrophages","volume":"281","author":"Yamada","year":"1997","journal-title":"J. Pharmacol. Experimental Therapeutics."},{"issue":"Suppl","key":"10.1016\/j.intimp.2021.108272_b0075","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1194\/jlr.R800042-JLR200","article-title":"Cyclooxygenases: structural and functional insights","volume":"50","author":"Rouzer","year":"2009","journal-title":"J. Lipid Res."},{"issue":"2\u20133","key":"10.1016\/j.intimp.2021.108272_b0080","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0014-2999(99)00053-9","article-title":"Inhibition by auranofin of the production of prostaglandin E2 and nitric oxide in rat peritoneal macrophages","volume":"368","author":"Yamashita","year":"1999","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2021.108272_b0085","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0014-2999(97)81943-7","article-title":"Induction of nitric oxide synthase by lipopolysaccharide and its inhibition by auranofin in RAW 264.7 cells","volume":"338","author":"Yamashita","year":"1997","journal-title":"Eur. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.intimp.2021.108272_b0090","first-page":"443","article-title":"Identification of an immediate early gene, pghs-B, whose protein product has prostaglandin synthase\/cyclooxygenase activity","volume":"3","author":"Ryseck","year":"1992","journal-title":"Cell Growth Differ."},{"issue":"11","key":"10.1016\/j.intimp.2021.108272_b0095","doi-asserted-by":"crossref","first-page":"4888","DOI":"10.1073\/pnas.89.11.4888","article-title":"cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase","volume":"89","author":"O'Banion","year":"1992","journal-title":"PNAS"},{"issue":"2","key":"10.1016\/j.intimp.2021.108272_b0100","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0031-6997(25)06663-3","article-title":"Nitric oxide: physiology, pathophysiology, and pharmacology","volume":"43","author":"Moncada","year":"1991","journal-title":"Pharmacol. Rev."},{"issue":"4","key":"10.1016\/j.intimp.2021.108272_b0105","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/014107689909200402","article-title":"Nitric oxide: discovery and impact on clinical medicine","volume":"92","author":"Moncada","year":"1999","journal-title":"J. R. Soc. Med."},{"key":"10.1016\/j.intimp.2021.108272_b0110","doi-asserted-by":"crossref","unstructured":"Yamashita, M., Yamaki, K., Ohuchi, K. Lipopolysaccharide-induced nitric oxide production in RAW 264.7 cells, and its inhibition by auranofin. In: S. Moncada, N. Toda, H. Maeda and E. A. Higgs. The Biology of Nitric Oxide, Part 6. London: Portland press Ltd; 1998. p. 242.","DOI":"10.1016\/S0021-5198(19)41749-6"},{"issue":"1","key":"10.1016\/j.intimp.2021.108272_b0115","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0092-8674(78)90101-0","article-title":"Functional macrophage cell lines transformed by abelson leukemia virus","volume":"15","author":"Raschke","year":"1978","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.intimp.2021.108272_b0120","doi-asserted-by":"crossref","first-page":"5981","DOI":"10.4049\/jimmunol.164.11.5981","article-title":"Thiol-reactive metal compounds inhibit NF-\u03baB activation by blocking I\u03baB kinase","volume":"164","author":"Jeon","year":"2000","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2021.108272_b0125","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1211\/002235702513","article-title":"Inhibition of TPA-induced NF-\u03baB nuclear translocation and production of NO and PGE2 by the anti-rheumatic gold compounds","volume":"55","author":"Yamashita","year":"2003","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.intimp.2021.108272_b0130","doi-asserted-by":"crossref","first-page":"e01947","DOI":"10.1128\/AAC.01947-16","article-title":"Phase I Clinical Trial Results of Auranofin, a Novel Antiparasitic Agent","volume":"61","author":"Capparelli","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.intimp.2021.108272_b0135","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2165\/00003088-198611020-00003","article-title":"Clinical pharmacokinetics of oral and injectable gold compounds","volume":"11","author":"Blocka","year":"1986","journal-title":"Clin. Pharmacokinet."},{"issue":"42","key":"10.1016\/j.intimp.2021.108272_b0140","doi-asserted-by":"crossref","first-page":"32775","DOI":"10.1074\/jbc.M003504200","article-title":"Molecular identification of cytosolic prostaglandin E2 synthase that is functionally coupled with cyclooxygenase-1 in immediate prostaglandin E2 biosynthesis","volume":"275","author":"Tanioka","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"42","key":"10.1016\/j.intimp.2021.108272_b0145","doi-asserted-by":"crossref","first-page":"32783","DOI":"10.1074\/jbc.M003505200","article-title":"Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2","volume":"275","author":"Murakami","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.intimp.2021.108272_b0150","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1016\/S0021-9258(19)39693-0","article-title":"Purification of unactivated progesterone receptor and identification of novel receptor-associated proteins","volume":"265","author":"Smith","year":"1990","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.intimp.2021.108272_b0155","first-page":"1956","article-title":"Characterization of a novel 23-kilodalton protein of unactive progesterone receptor complexes","volume":"14","author":"Johnson","year":"1994","journal-title":"Mol. Cell. Biol."},{"issue":"3","key":"10.1016\/j.intimp.2021.108272_b0160","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1083\/jcb.44.3.667","article-title":"Role of Mitochondria in the Handling of Gold by the Kidney","volume":"44","author":"Stuve","year":"1970","journal-title":"J. Cell Biol."},{"issue":"7","key":"10.1016\/j.intimp.2021.108272_b0165","first-page":"1064","article-title":"Effect of metal containing compounds on superoxide release from phorbol myristate acetate stimulated murine peritoneal macrophages: inhibition by auranofin and spirogermanium","volume":"15","author":"Mirabelli","year":"1988","journal-title":"J Rheumatol."},{"issue":"11","key":"10.1016\/j.intimp.2021.108272_b0170","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0006-2952(97)00015-4","article-title":"Serine protease inhibition and mitochondrial dysfunction associated with cisplatin resistance in human tumor cell lines: targets for therapy","volume":"53","author":"Dong","year":"1997","journal-title":"Biochem. Pharmacol."},{"issue":"10","key":"10.1016\/j.intimp.2021.108272_b0175","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/0006-2952(95)00033-V","article-title":"Induction of stress proteins in mouse peritoneal macrophages by the anti-rheumatic agents gold sodium thiomalate and auranofin","volume":"49","author":"Sato","year":"1995","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2021.108272_b0180","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.freeradbiomed.2015.12.008","article-title":"Enhanced targeting of mitochondrial peroxide defense by the combined use of thiosemicarbazones and inhibitors of thioredoxin reductase","volume":"91","author":"Myers","year":"2016","journal-title":"Free Radical Biol. Med."},{"issue":"36","key":"10.1016\/j.intimp.2021.108272_b0185","doi-asserted-by":"crossref","first-page":"34074","DOI":"10.1074\/jbc.M105383200","article-title":"Induction of cellular antioxidative stress genes through heterodimeric transcription factor Nrf2\/small Maf by antirheumatic gold(I) compounds","volume":"276","author":"Kataoka","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.intimp.2021.108272_b0190","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.1128\/MCB.22.15.5492-5505.2002","article-title":"Nrf2 Transcription Factor, a Novel Target of Keratinocyte Growth Factor Action Which Regulates Gene Expression and Inflammation in the Healing Skin Wound","volume":"22","author":"Braun","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.intimp.2021.108272_b0195","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.redox.2016.06.004","article-title":"A biphasic effect of TNF-\u03b1 in regulation of the Keap1\/Nrf2 pathway in cardiomyocytes","volume":"9","author":"Shanmugam","year":"2016","journal-title":"Redox Biol."},{"issue":"4","key":"10.1016\/j.intimp.2021.108272_b0200","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1172\/JCI25790","article-title":"Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis","volume":"116","author":"Thimmulappa","year":"2016","journal-title":"J. Clin. Investig."},{"issue":"10","key":"10.1016\/j.intimp.2021.108272_b0205","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1089\/ars.2015.6378","article-title":"TrxR1 as a Potent Regulator of the Nrf2-Keap1 Response System","volume":"23","author":"Cebula","year":"2015","journal-title":"Antioxid. Redox Signal."},{"issue":"11624","key":"10.1016\/j.intimp.2021.108272_b0210","doi-asserted-by":"crossref","first-page":"11624","DOI":"10.1038\/ncomms11624","article-title":"Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription","volume":"7","author":"Kobayashi","year":"2016","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.intimp.2021.108272_b0215","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.bjp.0703044","article-title":"Inhibition by troglitazone of the antigen-induced production of leukotrienes in immunoglobulin E-sensitized RBL-2H3 cells","volume":"129","author":"Yamashita","year":"2000","journal-title":"Br. J. Pharmacol."},{"issue":"1\u20133","key":"10.1016\/j.intimp.2021.108272_b0220","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejphar.2006.10.032","article-title":"Peroxisome proliferator-activated receptor \u03b1-independent effects of peroxisome proliferators on cysteinyl leukotriene production in mast cells","volume":"556","author":"Yamashita","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2021.108272_b0225","doi-asserted-by":"crossref","unstructured":"Yamashita, M. PPAR\u03b1\/\u03b3-independent effects of PPAR\u03b1\/\u03b3 ligands on cysteinyl leukotriene production in mast cells. PPAR Research. 2008;2008 Article ID 293538:1-6. https:\/\/doi.org\/10.1155\/2008\/293538.","DOI":"10.1155\/2008\/293538"},{"key":"10.1016\/j.intimp.2021.108272_b0230","doi-asserted-by":"crossref","unstructured":"Matthews, J. R., Wakasugi, N., virelizier, J.-L., et al. Thiordoxin regulates the DNA binding activity of NF-\u03baB by sreduction of a disulphid bond involving cysteine 62. Nucleic Acids Research. 1992;20(15):3821-3830. https:\/\/doi.org\/10.1093\/nar\/20.15.3821.","DOI":"10.1093\/nar\/20.15.3821"},{"issue":"10","key":"10.1016\/j.intimp.2021.108272_b0235","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.jinorgbio.2004.04.020","article-title":"Gold complexes inhibit mitochondrial thioredoxin reductase: consequences on mitochondrial functions","volume":"98","author":"Rigobello","year":"2004","journal-title":"J Inorg Biochem."},{"issue":"1","key":"10.1016\/j.intimp.2021.108272_b0240","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1042\/BJ20061809","article-title":"Mitochondrial respiratory chain and thioredoxin reductase regulate intermembrane Cu, Zn-superoxide dismutase activity: implications for mitochondrial energy metabolism and apoptosis","volume":"405","author":"Inarrea","year":"2007","journal-title":"Biochem J."},{"key":"10.1016\/j.intimp.2021.108272_b0245","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.redox.2016.01.007","article-title":"Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma","volume":"8","author":"Raninga","year":"2016","journal-title":"Redox Biol."},{"issue":"19","key":"10.1016\/j.intimp.2021.108272_b0250","doi-asserted-by":"crossref","first-page":"23071","DOI":"10.1038\/srep23071","article-title":"Mitochondrial Thioredoxin System as a Modulator of Cyclophilin D Redox State","volume":"6","author":"Folda","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.intimp.2021.108272_b0255","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3892\/or.2015.4382","article-title":"Auranofin induces mesothelioma cell death through oxidative stress and GSH depletion","volume":"35","author":"You","year":"2016","journal-title":"Oncol. Rep."},{"issue":"14","key":"10.1016\/j.intimp.2021.108272_b0260","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1021\/acs.jpca.6b01052","article-title":"Ligand Exchange Reaction of Au(I) R-N-Heterocyclic Carbene Complexes with Cysteine","volume":"120","author":"Dos Santos","year":"2016","journal-title":"J. Phys. Chem. A."},{"key":"10.1016\/j.intimp.2021.108272_b0265","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejphar.2017.02.021","article-title":"Butein induction of HO-1 by p38 MAPK\/Nrf2 pathway in adipocytes attenuates high-fat diet induced adipose hypertrophy in mice","volume":"799","author":"Wang","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.intimp.2021.108272_b0270","doi-asserted-by":"crossref","first-page":"L545","DOI":"10.1152\/ajplung.00214.2018","article-title":"The Thioredoxin Reductase Inhibitor Auranofin Induces Heme Oxygenase-1 in Lung Epithelial Cells Via Nrf2-dependent Mechanisms","volume":"315","author":"Dunigan","year":"2018","journal-title":"Am. J. Physiol.-Lung Cellular Mol. Physiol."},{"issue":"42","key":"10.1016\/j.intimp.2021.108272_b0275","doi-asserted-by":"crossref","first-page":"28977","DOI":"10.1074\/jbc.M109.020701","article-title":"Inhibition of Schistosoma mansoni thioredoxin-glutathione reductase by auranofin: structural and kinetic aspects","volume":"284","author":"Angelucci","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.intimp.2021.108272_b0280","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jsb.2016.02.015","article-title":"X-ray structures of thioredoxin and thioredoxin reductase from Entamoeba histolytica and prevailing hypothesis of the mechanism of Auranofin action","volume":"194","author":"Parsonage","year":"2016","journal-title":"J Struct Biol."},{"issue":"5","key":"10.1016\/j.intimp.2021.108272_b0285","doi-asserted-by":"crossref","first-page":"9593","DOI":"10.1021\/acsomega.9b00529","article-title":"Dynamic Basis for Auranofin Drug Recognition by Thiol-Reductases of Human Pathogens and Intermediate Coordinated Adduct Formation with Catalytic Cysteine Residues","volume":"4","author":"Abhishek","year":"2019","journal-title":"ACS Omega"},{"issue":"9","key":"10.1016\/j.intimp.2021.108272_b0290","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.7150\/thno.42903","article-title":"Nrf2 and HIF1\u03b1 converge to arsenic-induced metabolic reprogramming and the formation of the cancer stem-like cells","volume":"10","author":"Bi","year":"2020","journal-title":"Theranostics."},{"issue":"5","key":"10.1016\/j.intimp.2021.108272_b0295","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.freeradbiomed.2005.04.025","article-title":"Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds","volume":"39","author":"Witte","year":"2005","journal-title":"Free Radical Biol. Med."},{"issue":"8","key":"10.1016\/j.intimp.2021.108272_b0300","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1039\/C4MT00044G","article-title":"Ruthenium polypyridyl complexes as inducer of ROS-mediated apoptosis in cancer cells by targeting thioredoxin reductase","volume":"6","author":"Luo","year":"2014","journal-title":"Metallomics : integrated biometal science."},{"key":"10.1016\/j.intimp.2021.108272_b0305","doi-asserted-by":"crossref","first-page":"336","DOI":"10.3389\/fmicb.2018.00336","article-title":"Repurposing Auranofin, Ebselen, and PX-12 as Antimicrobial Agents Targeting the Thioredoxin System","volume":"9","author":"May","year":"2018","journal-title":"Front Microbiol."},{"issue":"3","key":"10.1016\/j.intimp.2021.108272_b0310","first-page":"153","article-title":"Risk assessment of green tea catechin for pharmacokinetic interaction with prescription drugs","volume":"43","author":"Yamashita","year":"2019","journal-title":"J. Drug Interaction Res."},{"issue":"56","key":"10.1016\/j.intimp.2021.108272_b0315","doi-asserted-by":"crossref","first-page":"96062","DOI":"10.18632\/oncotarget.21708","article-title":"Selection and characterization of a human ovarian cancer cell line resistant to auranofin","volume":"8","author":"Landini","year":"2017","journal-title":"Oncotarget."},{"issue":"3","key":"10.1016\/j.intimp.2021.108272_b0320","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1124\/dmd.108.023911","article-title":"The Inhibition of Human Multidrug and Toxin Extrusion 1 Is Involved in the Drug-Drug Interaction Caused by Cimetidine","volume":"37","author":"Matsushima","year":"2009","journal-title":"Drug Metab. Dispos."},{"issue":"8","key":"10.1016\/j.intimp.2021.108272_b0325","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1007\/s11095-006-9016-3","article-title":"Molecular Cloning, Functional Characterization and Tissue Distribution of Rat H+\/Organic Cation Antiporter MATE1","volume":"23","author":"Terada","year":"2006","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.intimp.2021.108272_b0330","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/ki.2014.66","article-title":"Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat","volume":"86","author":"Lepist","year":"2014","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.intimp.2021.108272_b0335","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.bcp.2013.07.008","article-title":"Role of organic cation transporter OCT2 and multidrug and toxin extrusion proteins MATE1 and MATE2-K for transport and drug interactions of the antiviral lamivudine","volume":"86","author":"M\u00fcller","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2021.108272_b0340","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bcp.2007.04.010","article-title":"Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions\/H+-organic cation antiporters","volume":"74","author":"Tanihara","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2021.108272_b0345","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1146\/annurev-pharmtox-010617-052713","article-title":"The SLC22 Transporter Family: A Paradigm for the Impact of Drug Transporters on Metabolic Pathways, Signaling, and Disease","volume":"58","author":"Nigam","year":"2018","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"6","key":"10.1016\/j.intimp.2021.108272_b0350","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0009-9236(03)00060-2","article-title":"Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: Consequences for pravastatin pharmacokinetics","volume":"73","author":"Nishizato","year":"2003","journal-title":"Clin. Pharmacol. Ther."},{"issue":"11","key":"10.1016\/j.intimp.2021.108272_b0355","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1248\/yakushi.131.1589","article-title":"Genetic Polymorphisms of SLCO1B1 for Drug Pharmacokinetics and Its Clinical Implications","volume":"131","author":"Takane","year":"2011","journal-title":"Yakugaku Zasshi"},{"key":"10.1016\/j.intimp.2021.108272_b0360","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.chemgeo.2016.05.024","article-title":"Applying the Midas touch: Differing toxicity of mobile gold and platinum complexes drives biomineralization in the bacterium Cupriavidus metallidurans","volume":"438","author":"Etschmann","year":"2016","journal-title":"Chem Geol."},{"issue":"1","key":"10.1016\/j.intimp.2021.108272_b0365","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1038\/s41467-019-10006-5","article-title":"Evidence for fungi and gold redox interaction under Earth surface conditions","volume":"10","author":"Bohu","year":"2019","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.intimp.2021.108272_b0370","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41419-017-0159-4","article-title":"Elimination of stem-like cancer cell side-population by auranofin through modulation of ROS and glycolysis","volume":"9","author":"Hou","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.intimp.2021.108272_b0375","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1038\/srep02014","article-title":"Common dysfunctional variants in ABCG2 are a major cause of early-onset gout","volume":"3","author":"Matsuo","year":"2013","journal-title":"Sci. Rep."},{"issue":"5212","key":"10.1016\/j.intimp.2021.108272_b0380","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1126\/science.7754369","article-title":"Identification and characterization of a prostaglandin transporter","volume":"268","author":"Kanai","year":"1995","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.intimp.2021.108272_b0385","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1172\/JCI118897","article-title":"Cloning, in vitro expression, and tissue distribution of a human prostaglandin transporter cDNA(hPGT)","volume":"98","author":"Lu","year":"1996","journal-title":"J. Clin. Investig."},{"issue":"3","key":"10.1016\/j.intimp.2021.108272_b0390","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1006\/bbrc.1998.8715","article-title":"Molecular Cloning of the Gene for the Human Prostaglandin Transporter hPGT: Gene Organization, Promoter Activity, and Chromosomal Localization","volume":"246","author":"Lu","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.intimp.2021.108272_b0395","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2133\/dmpk.19.171","article-title":"The Organic Anion Transporter (OATP) Family","volume":"19","author":"Mikkaichi","year":"2004","journal-title":"Drug Metab. Pharmacokinet."},{"issue":"2","key":"10.1016\/j.intimp.2021.108272_b0400","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/1479-7364-3-2-195","article-title":"Analysis and update of the human solute carrier (SLC) gene superfamily","volume":"3","author":"He","year":"2009","journal-title":"Human Genomics."},{"issue":"16","key":"10.1016\/j.intimp.2021.108272_b0405","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/0161-5890(93)90106-L","article-title":"Construction and initial characterization of a mouse-human chimeric anti-TNF antibody","volume":"30","author":"Knight","year":"1993","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.intimp.2021.108272_b0410","article-title":"Auranofin versus placebo in rheumatoid arthritis","volume":"2","author":"Suarez-Almazor","year":"2000","journal-title":"Cochrane Database Systematic Rev."},{"key":"10.1016\/j.intimp.2021.108272_b0415","doi-asserted-by":"crossref","unstructured":"Editoreal. The Gold Treatment of Tuberculosis. American Journal of Public Health (New York). 1925;15(7):631-631. https:\/\/doi.org\/10.2105\/ajph.15.7.631-a.","DOI":"10.2105\/AJPH.15.7.631-a"},{"key":"10.1016\/j.intimp.2021.108272_b0420","doi-asserted-by":"crossref","unstructured":"Editoreal. Sanocrysin\u2014A Gold Cure for Tuberculosis. American Journal of Public Health (New York). 1925;15(2):144-145. https:\/\/doi.org\/10.2105\/ajph.15.2.144.","DOI":"10.2105\/AJPH.15.2.144"},{"issue":"3355","key":"10.1016\/j.intimp.2021.108272_b0425","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/bmj.1.3355.735","article-title":"The Gold Treatment of Tuberculosi","volume":"1","author":"Council","year":"1925","journal-title":"British Med. J."},{"issue":"3420","key":"10.1016\/j.intimp.2021.108272_b0430","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/bmj.2.3420.158","article-title":"The Gold Treatment of Tuberculosis: Second Report by the Medical Research Council","volume":"2","author":"Council","year":"1926","journal-title":"British Med. J."},{"issue":"7","key":"10.1016\/j.intimp.2021.108272_b0435","first-page":"741","article-title":"The Gold Treatment of Tuberculosis Again","volume":"15","author":"Malloch","year":"1925","journal-title":"Can. Med. Assoc. J."},{"issue":"1","key":"10.1016\/j.intimp.2021.108272_b0440","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1093\/jhmas\/jrg042","article-title":"The history of gold therapy for tuberculosis","volume":"59","author":"Benedek","year":"2004","journal-title":"J. Hist. Med. Allied Sci."},{"issue":"3","key":"10.1016\/j.intimp.2021.108272_b0445","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1128\/jb.52.3.393-397.1946","article-title":"Isolation of Streptomycin-producing Strains of Streptomyces griseus12","volume":"52","author":"Waksman Selman","year":"1946","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.intimp.2021.108272_b0450","first-page":"641","article-title":"The effect of streptomycin on the histopathology of human tuberculosis","volume":"22","author":"Baggenstoss","year":"1946","journal-title":"Am J Pathol."},{"issue":"2","key":"10.1016\/j.intimp.2021.108272_b0455","first-page":"120","article-title":"Selman Abraham Waksman and the discovery of streptomycin Founders of Our Knowledge","volume":"9","author":"Daniel","year":"2005","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"12","key":"10.1016\/j.intimp.2021.108272_b0460","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.3899\/jrheum.150057","article-title":"The Risk of Tuberculosis in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor-\u03b1 Antagonist: A Metaanalysis of Both Randomized Controlled Trials and Registry\/Cohort Studies","volume":"42","author":"Ai","year":"2015","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.intimp.2021.108272_b0465","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(20)30448-3","article-title":"Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial","author":"Wallis","year":"2021","journal-title":"Lancet Respiratory Med."},{"issue":"7","key":"10.1016\/j.intimp.2021.108272_b0470","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/annrheumdis-2020-217871","article-title":"Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry","volume":"79","author":"Gianfrancesco","year":"2020","journal-title":"Ann Rheum Dis."},{"issue":"2","key":"10.1016\/j.intimp.2021.108272_b0475","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41584-020-00562-2","article-title":"Rheumatic disease and COVID-19: epidemiology and outcomes","volume":"17","author":"Hyrich","year":"2021","journal-title":"Nat. Rev. Rheumatol."},{"issue":"547","key":"10.1016\/j.intimp.2021.108272_b0480","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.virol.2020.05.002","article-title":"The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells","volume":"2020","author":"Rothan","year":"2020","journal-title":"Virology"},{"issue":"66","key":"10.1016\/j.intimp.2021.108272_b0485","doi-asserted-by":"crossref","first-page":"15140","DOI":"10.1002\/chem.202004112","article-title":"Gold Metallodrugs to Target Coronavirus Proteins: Inhibitory Effects on the Spike-ACE2 Interaction and on PLpro Protease Activity by Auranofin and Gold Organometallics","volume":"26","author":"Gil-Moles","year":"2020","journal-title":"Chemistry."},{"issue":"45","key":"10.1016\/j.intimp.2021.108272_b0490","doi-asserted-by":"crossref","first-page":"16004","DOI":"10.1039\/D0DT02478C","article-title":"What is holding back the development of antiviral metallodrugs? A literature overview and implications for SARS-CoV-2 therapeutics and future viral outbreaks","volume":"49","author":"de Paiva","year":"2020","journal-title":"Dalton Trans."},{"issue":"1","key":"10.1016\/j.intimp.2021.108272_b0495","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/17460441.2020.1819236","article-title":"Metallo therapeutics for COVID-19. Exploiting metal-based compounds for the discovery of new antiviral drugs","volume":"16","author":"Cirri","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"issue":"6","key":"10.1016\/j.intimp.2021.108272_b0500","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1021\/acsptsci.0c00130","article-title":"Ebselen, disulfiram, carmofur, PX-12, tideglusib, and shikonin are non-specific promiscuous SARS-CoV-2 main protease inhibitors","volume":"3","author":"Ma","year":"2020","journal-title":"ACS Pharmacol. Translational Sci."},{"key":"10.1016\/j.intimp.2021.108272_b0505","article-title":"COVID-19: inflammatory responses, structure-based drug design and potential therapeutics","volume":"1\u201317","author":"Tripathi","year":"2021","journal-title":"Mol. Diversity"},{"key":"10.1016\/j.intimp.2021.108272_b0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104610","article-title":"A connectivity map-based drug repurposing study and integrative analysis of transcriptomic profiling of SARS-CoV-2 infection","volume":"86","author":"Mousavi","year":"2020","journal-title":"Infection, Genetics Evolution"},{"issue":"1","key":"10.1016\/j.intimp.2021.108272_b0515","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.1038\/s41467-020-18764-3","article-title":"SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate","volume":"11","author":"Olagnier","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.intimp.2021.108272_b0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2020.106451","article-title":"SARS-CoV-2\/COVID-19 in multiple sclerosis patients receiving disease-modifying therapy","volume":"201","author":"Adamczyk-Sowa","year":"2021","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"10","key":"10.1016\/j.intimp.2021.108272_b0525","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1177\/1352458520942198","article-title":"COVID-19 in multiple sclerosis: The Dutch experience","volume":"26","author":"Loonstra","year":"2020","journal-title":"Multiple Sclerosis J."},{"issue":"1","key":"10.1016\/j.intimp.2021.108272_b0530","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12952-017-0070-7","article-title":"The effects of phosphanegold(I) thiolates on the biological properties of Acanthamoeba castellanii belonging to the T4 genotype","volume":"16","author":"Siddiqui","year":"2017","journal-title":"J. Negat. Results Biomed."},{"issue":"4","key":"10.1016\/j.intimp.2021.108272_b0535","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/jeu.12706","article-title":"Anti-Parasitic Activity of Auranofin Against Pathogenic Naegleria fowleri","volume":"66","author":"Peroutka-Bigus","year":"2019","journal-title":"J. Eukaryot. Microbiol."},{"issue":"16","key":"10.1016\/j.intimp.2021.108272_b0540","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1021\/acschemneuro.0c00165","article-title":"Activity of Auranofin against Multiple Genotypes of Naegleria fowleri and its Synergistic Effect with Amphotericin B in vitro","volume":"11","author":"Escrig","year":"2020","journal-title":"ACS Chem. Neurosci."},{"issue":"3","key":"10.1016\/j.intimp.2021.108272_b0545","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1074\/jbc.M115.695007","article-title":"Leishmania donovani Encodes a Functional Selenocysteinyl-tRNA Synthase","volume":"291","author":"Manhas","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2021.108272_b0550","doi-asserted-by":"crossref","first-page":"22571","DOI":"10.1038\/srep22571","article-title":"Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens","volume":"6","author":"Thangamani","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2021.108272_b0555","doi-asserted-by":"crossref","unstructured":"Liu, G., Wu, Y., Jin, S., et al. Itaconate ameliorates methicillin-resistant Staphylococcus aureus -induced acute lung injury through the Nrf2\/ARE pathway. Annals of Translational Medicine; Vol 9, No 8 (April 2021): Annals of Translational Medicine. 2021. https:\/\/atm.amegroups.com\/article\/view\/68197.","DOI":"10.21037\/atm-21-1448"},{"issue":"14","key":"10.1016\/j.intimp.2021.108272_b0560","doi-asserted-by":"crossref","DOI":"10.1093\/femsle\/fnw148","article-title":"Auranofin and N-heterocyclic carbene gold-analogs are potent inhibitors of the bacteria Helicobacter pylori","volume":"363","author":"Owings","year":"2016","journal-title":"FEMS Microbiol. Lett."},{"issue":"2","key":"10.1016\/j.intimp.2021.108272_b0565","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4155\/fmc.15.182","article-title":"Inhibition of bacterial and fungal pathogens by the orphaned drug auranofin","volume":"8","author":"Fuchs","year":"2016","journal-title":"Future Med. Chem."},{"issue":"2","key":"10.1016\/j.intimp.2021.108272_b0570","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/21505594.2016.1196301","article-title":"Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungi","volume":"8","author":"Wiederhold","year":"2017","journal-title":"Virulence."},{"issue":"1","key":"10.1016\/j.intimp.2021.108272_b0575","doi-asserted-by":"crossref","first-page":"7701","DOI":"10.1038\/s41598-020-64882-9","article-title":"Auranofin, at clinically achievable dose, protects mice and prevents recurrence from Clostridioides difficile infection","volume":"10","author":"Abutaleb","year":"2020","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.intimp.2021.108272_b0580","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ijantimicag.2019.08.001","article-title":"Potential impact of the antirheumatic agent auranofin on proviral HIV-1 DNA in individuals under intensified antiretroviral therapy: Results from a randomised clinical trial","volume":"54","author":"Diaz","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.intimp.2021.108272_b0585","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.antiviral.2017.04.014","article-title":"Host oxidative folding pathways offer novel anti-chikungunya virus drug targets with broad spectrum potential","volume":"143","author":"Langsjoen","year":"2017","journal-title":"Antiviral Res."},{"issue":"2","key":"10.1016\/j.intimp.2021.108272_b0590","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00775-016-1338-y","article-title":"Novel antitumor adamantane-azole gold(I) complexes as potential inhibitors of thioredoxin reductase","volume":"21","author":"Garcia","year":"2016","journal-title":"J. Biological Inorganic Chem. : JBIC: A publication Society Biological Inorganic Chem."},{"issue":"6","key":"10.1016\/j.intimp.2021.108272_b0595","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1039\/C5DT01802A","article-title":"In vitro and in vivo evaluation of organometallic gold(I) derivatives as anticancer agents","volume":"45","author":"Garcia-Moreno","year":"2016","journal-title":"Dalton Trans."},{"issue":"3","key":"10.1016\/j.intimp.2021.108272_b0600","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.18632\/oncotarget.6425","article-title":"Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo","volume":"7","author":"Huang","year":"2016","journal-title":"Oncotarget."},{"issue":"6","key":"10.1016\/j.intimp.2021.108272_b0605","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.3390\/molecules23061410","article-title":"Gold-Based Medicine: A Paradigm Shift in Anti-Cancer Therapy?","volume":"23","author":"Yeo","year":"2018","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.intimp.2021.108272_b0610","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.redox.2015.12.004","article-title":"The thioredoxin system in breast cancer cell invasion and migration","volume":"8","author":"Bhatia","year":"2016","journal-title":"Redox Biol."},{"issue":"3","key":"10.1016\/j.intimp.2021.108272_b0615","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.18632\/oncotarget.6516","article-title":"Auranofin-mediated inhibition of PI3K\/AKT\/mTOR axis and anticancer activity in non-small cell lung cancer cells","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget."},{"key":"10.1016\/j.intimp.2021.108272_b0620","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bcp.2016.01.004","article-title":"Sensitization of acute lymphoblastic leukemia cells for LCL161-induced cell death by targeting redox homeostasis","volume":"105","author":"Ha\u00df","year":"2016","journal-title":"Biochem. Pharmacol."},{"issue":"22","key":"10.1016\/j.intimp.2021.108272_b0625","doi-asserted-by":"crossref","first-page":"35728","DOI":"10.18632\/oncotarget.16113","article-title":"Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget."},{"issue":"8","key":"10.1016\/j.intimp.2021.108272_b0630","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1039\/C6DT04862E","article-title":"Mononuclear gold(III) complexes with l-histidine-containing dipeptides: tuning the structural and biological properties by variation of the N-terminal amino acid and counter anion","volume":"46","author":"Warzajtis","year":"2017","journal-title":"Dalton Trans."},{"key":"10.1016\/j.intimp.2021.108272_b0635","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.ejmech.2016.10.052","article-title":"Novel gold(I) complexes with 5-phenyl-1,3,4-oxadiazole-2-thione and phosphine as potential anticancer and antileishmanial agents","volume":"127","author":"Chaves","year":"2017","journal-title":"Eur. J. Medicinal Chem."},{"issue":"3","key":"10.1016\/j.intimp.2021.108272_b0640","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1248\/cpb.c18-00767","article-title":"Potential Anticancer Activity of Auranofin","volume":"67","author":"Onodera","year":"2019","journal-title":"Chem. Pharm. Bull."},{"issue":"22","key":"10.1016\/j.intimp.2021.108272_b0645","doi-asserted-by":"crossref","first-page":"12446","DOI":"10.1002\/anie.202100369","article-title":"Prodrug activation by gold artificial metalloenzyme-catalyzed synthesis of phenanthridinium derivatives via hydroamination","volume":"60","author":"Chang","year":"2021","journal-title":"Angew. Chem. Int. Ed."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921009085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576921009085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:31:07Z","timestamp":1761586267000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576921009085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":129,"alternative-id":["S1567576921009085"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108272","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Auranofin: Past to Present, and repurposing","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2021.108272","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108272"}}